These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9376663)

  • 1. Cytogenetics of chronic myelogenous leukaemia.
    O'Brien S; Thall PF; Siciliano MJ
    Baillieres Clin Haematol; 1997 Jun; 10(2):259-76. PubMed ID: 9376663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypermetaphase fluorescence in situ hybridization for quantitative monitoring of Philadelphia chromosome-positive cells in patients with chronic myelogenous leukemia during treatment.
    Seong DC; Kantarjian HM; Ro JY; Talpaz M; Xu J; Robinson JR; Deisseroth AB; Champlin RE; Siciliano MJ
    Blood; 1995 Sep; 86(6):2343-9. PubMed ID: 7662980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early detection of relapse by hypermetaphase fluorescence in situ hybridization after allogeneic bone marrow transplantation for chronic myeloid leukemia.
    Seong CM; Giralt S; Kantarjian H; Xu J; Swantkowski J; Hayes K; Glassman AB; Khouri I; Korbling M; Thall P; Siciliano MJ; Champlin RE
    J Clin Oncol; 2000 May; 18(9):1831-6. PubMed ID: 10784623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical detection of BCR-abl fusion by in situ hybridization in chronic myelogenous leukemia.
    Amiel A; Yarkoni S; Fejgin M; Gaber E; Nagler A; Manor Y; Lishner M
    Cancer Genet Cytogenet; 1993 Jan; 65(1):32-4. PubMed ID: 8431913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of the Mbcr/abl translocation in chronic myeloid leukemia by fluorescence in situ hybridization: comparison with conventional cytogenetics and implications for minimal residual disease detection.
    Garcia-Isidoro M; Tabernero MD; Garcia JL; Najera ML; Hernandez JM; Wiegant J; Raap A; San Miguel J; Orfao A
    Hum Pathol; 1997 Feb; 28(2):154-9. PubMed ID: 9023395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypermetaphase and interphase fluorescence in situ hybridisation for monitoring of remission status in Philadelphia chromosome positive chronic myeloid leukaemia.
    Duba HC; Hilbe W; Mehringer A; Erdel M; Thaler J; Utermann G
    Int J Oncol; 2000 Dec; 17(6):1245-9. PubMed ID: 11078812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Philadelphia chromosome-positive myeloid cells in the peripheral blood of chronic myelogenous leukemia patients: comparison with the frequency detected in cycling cells of the bone marrow.
    Seong D; Thall P; Kantarjian HM; Talpaz M; Swantkowski J; Xu J; Shen Y; Glassman A; Ramagli L; Siciliano MJ
    Clin Cancer Res; 1998 Apr; 4(4):861-7. PubMed ID: 9563879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular cytogenetic characterization of variant Philadelphia translocations in chronic myeloid leukemia: genesis and deletion of derivative chromosome 9.
    Bennour A; Sennana H; Laatiri MA; Elloumi M; Khelif A; Saad A
    Cancer Genet Cytogenet; 2009 Oct; 194(1):30-7. PubMed ID: 19737651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of the breakpoint cluster region-ABL fusion in chronic myeloid leukemia with variant Philadelphia chromosome translocations by in situ hybridization.
    Tosi S; Cabot G; Giudici G; Attuati V; Morandi P; Rambaldi A; Döhner H; Biondi A
    Cancer Genet Cytogenet; 1996 Jul; 89(2):153-6. PubMed ID: 8697423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complex chromosome rearrangements may locate the bcr/abl fusion gene sites other than 22q11.
    Sessarego M; Fugazza G; Bruzzone R; Ballestrero A; Miglino M; Bacigalupo A
    Haematologica; 2000 Jan; 85(1):35-9. PubMed ID: 10629589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical implications of fluorescence in situ hybridization analysis in 13 chronic myeloid leukemia cases: Ph-negative and variant Ph-positive.
    Yehuda O; Abeliovich D; Ben-Neriah S; Sverdlin I; Cohen R; Varadi G; Orr R; Ashkenazi YJ; Heyd J; Lugassy G; Ben Yehuda D
    Cancer Genet Cytogenet; 1999 Oct; 114(2):100-7. PubMed ID: 10549264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of chromosome banding analysis, interphase- and hypermetaphase-FISH, qualitative and quantitative PCR for diagnosis and for follow-up in chronic myeloid leukemia: a study on 350 cases.
    Schoch C; Schnittger S; Bursch S; Gerstner D; Hochhaus A; Berger U; Hehlmann R; Hiddemann W; Haferlach T
    Leukemia; 2002 Jan; 16(1):53-9. PubMed ID: 11840263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic role of conventional cytogenetics and fluorescence in situ hybridization (FISH) in chronic myeloid leukemia patients.
    Jha CB; Kucheria K; Choudhary VP
    Kathmandu Univ Med J (KUMJ); 2006; 4(2):171-5. PubMed ID: 18603893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Variant Philadelphia chromosome identified by interphase fluorescence in situ hybridization (FISH) without evidence on G-banded karyotyping and metaphase FISH].
    Kim MK; Mun YC; Seong CM; Chung WS; Huh J
    Korean J Lab Med; 2010 Dec; 30(6):711-7. PubMed ID: 21157160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular cytogenetics of chronic myeloid leukemia with atypical t(6;9) (p23;q34) translocation.
    Jadayel D; Calabrese G; Min T; van Rhee F; Swansbury GJ; Dyer MJ; Maitland J; Palka G; Catovsky D
    Leukemia; 1995 Jun; 9(6):981-7. PubMed ID: 7596189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variant Philadelphia translocations in chronic myeloid leukaemia can mimic typical blast crisis chromosome abnormalities or classic t(9;22): a report of two cases.
    Reid A; Gribble SM; Huntly BJ; Andrews KM; Campbell L; Grace CD; Wood ME; Green AR; Nacheva EP
    Br J Haematol; 2001 May; 113(2):439-42. PubMed ID: 11380413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies of complex Ph translocations in cases with chronic myelogenous leukemia and one with acute lymphoblastic leukemia.
    Costa D; Carrió A; Madrigal I; Arias A; Valera A; Colomer D; Aguilar JL; Teixido M; Camós M; Cervantes F; Campo E
    Cancer Genet Cytogenet; 2006 Apr; 166(1):89-93. PubMed ID: 16616117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Analysis and identification of variant Ph chromosome translocation in patients with chronic myelogenous leukemia by conventional cytogenetics and fluorescence in situ hybridization].
    Liu XP; Liu SH; Li CW; Bo LJ; Qin S; Dai Y; Qian LS
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Jun; 12(3):298-303. PubMed ID: 15228654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of fluorescence in situ hybridization in defining a complex t(9;21;22) Ph formation.
    Mancini M; Nanni M; Cedrone M; De Cuia MR; Rondinelli MB; Malagnino F; Alimena G
    Haematologica; 1994; 79(6):536-9. PubMed ID: 7896212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Fluorescent in-situ hybridization technique (FISH) in the diagnosis of Philadelphia translocation in chronic myeloid leukemia].
    Martinet D; Mühlematter D; Jotterand Bellomo M
    Schweiz Med Wochenschr; 1996 May; 126(20):855-63. PubMed ID: 8685681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.